Skip to main navigation Skip to search Skip to main content

AstraZeneca AB: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Treatment of Physician's Choice in Participants with B7-H4-Positive Advanced/Metastatic Endometrial Cancer

Project: Research

Project Details

StatusActive
Effective start/end date02/13/2605/22/27

Funding

  • GOG Foundation Incorporated: $1.00